Denali Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,400	Closed	-$185K	–	541
2023 Q2	$185K	Buy	11,400 +8,100	+245%	+$131K	0.06%	223
2023 Q1	$54.9K	Buy	+3,300	New	+$54.9K	0.02%	214